LetMbe a compact Riemannian manifold of dimension n > 2. The k-curvature, for k = 1, 2, . . . , n, is defined as the k-th ele- mentary symmetric polynomial of the eigenvalues of the Schouten tenser. The k-Yamabe problem is to prove the existence of a con- formal metric whose k-curvature is a constant. When k = 1, it reduces to the well-known Yamabe problem. Under the assumption that the metric is admissible, the existence of solutions is known for the case k = 2, n = 4, for locally conformally flat manifolds and for the cases k > n/2. In this paper we prove the solvability of the k-Yamabe problem in the remaining cases k ≤ n/2, under the hypothesis that the problem is variational. This includes all of the cases k = 2 as well as the locally conformally flat case.

In this paper, we study the classical Allen-Cahn equations and investigate the maximum-principle-preserving (MPP) techniques. The Allen-Cahn equation has been widely used in mathematical models for problems in materials science and fluid dynamics. It enjoys the energy stability and the maximum-principle. Moreover, it is well known that the Allen-Cahn equation may yield thin interface layer, and nonuniform meshes might be useful in the numerical solutions. Therefore, we apply the local discontinuous Galerkin (LDG) method due to its flexibility on h-p adaptivity and complex geometry. However, the MPP LDG methods require slope limiters, then the energy stability may not be easy to obtain. In this paper, we only discuss the MPP technique and use numerical experiments to demonstrate the energy decay property. Moreover, due to the stiff source given in the equation, we use the conservative modified exponential Runge-Kutta methods and thus can use relatively large time step sizes. Thanks to the conservative time integration, the bounds of the unknown function will not decay. Numerical experiments will be given to demonstrate the good performance of the MPP LDG scheme.

There is an unmet medical need to identify neuroimaging biomarkers that is able to accurately diagnose and monitor Alzheimer's disease (AD) at very early stages and assess the response to AD-modifying therapies. To a certain extent, volumetric and functional magnetic resonance imaging (fMRI) studies can detect changes in structure, cerebral blood flow and blood oxygenation that are able to distinguish AD and mild cognitive impairment (MCI) subjects from normal controls. However, it has been challenging to use fully automated MRI analytic methods to identify potential AD neuroimaging biomarkers. We have thus proposed a method based on independent component analysis (ICA), for studying potential AD-related MR image features, coupled with the use of support vector machine (SVM) for classifying scans into categories of AD, MCI, and normal control (NC) subjects. The MRI data were selected from Open Access Series of Imaging Studies (OASIS) and the Alzheimer's Disease Neuroimaging Initiative (ADNI) databases. The experimental results showed that our ICA-based method can differentiate AD and MCI subjects from normal controls, although further methodological improvement in the analytic method and inclusion of additional variables may be required for optimal classification.

No abstract uploaded!

No abstract uploaded!